ACTB pseudogene 2 (ACTBP2)

ACTB pseudogene 2 is a processed pseudogene—an inactive, non-protein-coding sequence in the human genome—derived from the ACTB gene, which encodes the cytoskeletal protein beta-actin. Pseudogenes such as ACTBP2 retain sequence similarity to parental genes but lack the ability to encode functional proteins due to disabling mutations or lack of regulatory elements. Numerous ACTB pseudogenes exist in the human genome, posing challenges for molecular assays that target ACTB sequences, as nonspecific amplification or mispriming can occur[6][5]. ACTBP2 itself does not encode a protein, is not a therapeutic target, and is not associated with disease or clinical applications. The functionally relevant counterpart in research and medicine is the beta-actin protein encoded by the ACTB gene[1][3][5]. In summary: ACTBP2 (ACTB pseudogene 2) is not a canonical target, abbreviation, nor a druggable entity. It should not be used for therapeutic or biomarker purposes, and the query likely describes an incorrect or non-applicable target regarding drug discovery and disease association[6][5].

Mechanism of drug action is not applicable to pseudogenes.